Bengaluru (Karnataka) [India], July 24: Nesa Medtech (Nesa), a private medical device company addressing clinical unmet needs for patients with symptomatic uterine fibroids, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company's F
Chennai (Tamil Nadu) [India], July 24: Acentra Health welcomed U.S. Consul General in Chennai Judith Ravin at a celebration in Chennai on Friday, July 21, 2023, to inaugurate the U.S.-based company’s new brand and its continued investment in its growing India-based technology development wor
Radiation therapy for patients with prostate cancer can be made safer by a method that uses imaging technology as a guide. This method enables doctors to precisely direct radiation beams towards the prostate while avoiding adjacent tissue in the bladder, urethra, and rectum.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
As part of the partnership, PureHealth will be introducing Fujifilm’s advanced Healthcare IT products. The Abu Dhabi Health Services Company (SEHA), one of the largest networks of hospitals and clinics in the UAE, a PureHealth subsidiary, will be the first beneficiary, deploying the state-of
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
Bangalore (Karnataka) [India], July 21: Kosmoderma recently launched its new technological innovation with Regenerative Medicine in India. Founder and CEO of Kosmoderma, Dr. Chytra V. Anand unveiled the new service of the clinic on July 6 along with 25 other esteemed clients at Kosmoderma’s
The majority of women with ovarian cancer are diagnosed with the most advanced stage of the disease. Less than a third of people diagnosed with the condition survive five years. According to a recent study, as the third most frequent type of gynaecological cancer, it caused more than 200,000
Seoul [South Korea], July 19: Daewoong Pharmaceutical obtained approval for a SGLT-2 inhibitor+metformin combination drug in just one month after the release of Envlo Tab., the 1st SGLT-2 inhibitor by Korea, expanding its product portfolio.
Hyderabad (Telangana) [India], July 18: The goal of the collaboration is to reduce the time and resources it takes to translate a biomedical breakthrough into a clinically and commercially viable medicine.
Multiple organ inflammation is a hallmark of systemic autoimmune disorders, which can have disastrous effects on patients. Treatments for these disorders are desperately needed. In some clinical trials, RNase therapies appear promising, but not in all. The causes of this variability have bee
The five-year survival rate for all children with acute lymphatic leukaemia (ALL) has risen to 94 per cent. A study of 800 Dutch youngsters demonstrates this. Modified treatment procedures for four subgroups were investigated in the research. The changes were discovered to have a favourable